Neutralising antibodies against interferon-β and their correlation with clinical and magnetic resonance imaging activity in Japanese multiple sclerosis patients

被引：0
|
作者：
Sato, D.
Nakashima, I.
Fukazawa, T.
Shimizu, Y.
Tomizawa, Y.
Yokoyama, K.
Misu, T.
Itoyama, Y.
Aoki, M.
Fujihara, K.
机构：
[1] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan
[2] Sapporo Neurol Clin, Sapporo, Hokkaido, Japan
[3] Tokyo Womens Med Univ, Sch Med, Tokyo, Japan
[4] Juntendo Univ, Sch Med, Tokyo 113, Japan
[5] Natl Ctr Neurol & Psychiat, Tokyo, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：471 / 471
页数：1
相关论文
共 50 条
  • [1] PRESERVED IN VIVO RESPONSE TO INTERFERON-α IN MULTIPLE SCLEROSIS PATIENTS WITH NEUTRALISING ANTIBODIES AGAINST INTERFERON-β: AN ONGOING CLINICAL TRIAL
    Magyari, M.
    Sondergaard, H. B.
    Sellebjerg, F.
    Sorensen, P. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 272 - 272
  • [2] Clinical efficacy and neutralising antibodies in multiple sclerosis patients treated with interferon-β
    D'hooghe, MB
    Nagels, G
    Van Remoortel, A
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S254 - S254
  • [3] In-vivo response to interferon-α is preserved in multiple sclerosis patients with neutralising antibodies against interferon-β
    Magyari, M.
    Sondergaard, H. Bach
    Sellebjerg, F.
    Sorensen, P. Soelberg
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 202 - 202
  • [4] Neutralising antibodies against interferon in 379 patients with multiple sclerosis
    Frederiksen, J. L.
    Beyer, N. H.
    MULTIPLE SCLEROSIS, 2006, 12 : S204 - S204
  • [5] Neutralising antibodies against interferon beta in multiple sclerosis
    Mikol, D
    LANCET, 2004, 363 (9403): : 167 - 168
  • [6] Neutralising antibodies to interferon-β in the treatment of multiple sclerosis -: Cause for concern?
    Paszner, B
    Petkau, J
    Oger, J
    CNS DRUGS, 1999, 11 (03) : 225 - 243
  • [7] Effect of neutralising antibodies against interferon-β on in vivo biologic response and disease control in multiple sclerosis patients
    Sorensen, PS
    Tscherning, T
    Ross, C
    Mathiesen, HK
    Langkilde, A
    Clemmesen, K
    Bendtzen, K
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S253 - S254
  • [8] A weighted genetic risk score to predict neutralising antibodies to interferon-β in multiple sclerosis patients
    Hemmer, B.
    Igl, W.
    Buck, D.
    Muehlau, M.
    Schwenke, S.
    Mueller-Myhsok, B.
    Sandbrink, R.
    Pohl, C.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 361 - 361
  • [9] Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis
    Sorensen, PS
    Ross, C
    Clemmesen, KM
    Bendtzen, K
    Frederiksen, JL
    Jensen, K
    Kristensen, O
    Petersen, T
    Rasmussen, S
    Ravnborg, M
    Stenager, E
    Koch-Henriksen, N
    LANCET, 2003, 362 (9391): : 1184 - 1191
  • [10] Pharmacodynamics of interferon-β in relapsing-remitting multiple sclerosis with and without neutralising antibodies
    Scagnolari, G
    Duda, P
    Alberelli, A
    Lavolpe, V
    Bagnato, F
    Girardi, E
    Trojano, M
    Kappos, L
    Antonelli, G
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S255 - S255
12345